Not Yet Recruiting Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1 NCT06777264 Conditions Acute Lymphoblastic Leukemia, B Cell ALL, Burkitt Lymphoma, +20 more Locations Not specified View Trial Details
Active, Not Recruiting A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy NCT04148430 Conditions B Cell ALL, B-cell Lymphoma, B-cell Non Hodgkin Lymphoma, +17 more Locations Hackensack Meridian Health (Data collection only) — Hackensack, New Jersey, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
